We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52119 679 3 CRSP
Emcee:  Biomaven Type:  Moderated
Biotech stocks are a close second only to internet stocks in how difficult they are to objectively value. This means that biotech stocks can be wildly under- or over-valued, which creates an opportunity for either profit or frustration for an investor that "knows better than market." To paraphrase the master: "Every now and again you should look at the stock price to see if the market is offering to do anything stupid."

This thread grew out of the "Munch-a-Biotech" thread, and is meant to discuss biotech stock valuation methods of all sorts, as well as particular stocks or sectors you may feel are under- or over-valued.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
52119Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’s Peoplesoftware salesperson2May 7 A Big Week for GLP-1 Drugs A Breakthrough Award, Nesoftware salesperson-May 3
52117Sorry don't follow them but they have a $5 billion plus market cap so they mJamesK-May 1
52116IBRX anyone? Any holders, buyers, sellers, opinions, suggestions, complaints or Aloner-April 26
52115Yes. Compare VINC to the great VKTX offering. The xbi run up over 100 has allowJamesK-April 26
52114That's how it always goes with biotechs. If they can't license the drug,Sun Tzu-April 25
52113VINC - sorry I ever mentioned this one. After declining all the way back down thJamesK-April 25
52112Wow! Amazing!Sun Tzu-March 29
52111VINC was .61 at bottom in the bio bear. Now over 9. There's a lot of these lJamesK-March 11
52110VKTX - up on take over rumor. Seems unlikely before we see data on their drugs. JamesK-February 16
52109ARGUS Opinion: Since 2021, the biotechnology industry has underperformed the broAloner1January 24
52108additional reasons over and above fewer side effects that novavax is better thansoftware salesperson2January 21
52107Does anyone know of a market cap weighted broad biotech ETF? I am looking for soSun Tzu-January 5
521062024 Biotech Charity Contest Up & Running! Come one, come all, pick your btechnetium-12/29/2023 Serious Medical Errors Rose After Private Equity Firms Bought Hospisoftware salesperson212/27/2023
52104eric topol's latest substack on covid, nasal vaccines, long covid and, unforsoftware salesperson112/17/2023
52103here is a follow-up freakonomics podcast on how PE firms operate in general rathsoftware salesperson111/28/2023
52102Re: CRSP Trade History.................................. Since adding CRSP to mOldAIMGuy111/20/2023 novavax locator - - open appts. in your area in 2nd to last paragrasoftware salesperson111/20/2023
52100TENX up 295% CHAPEL HILL, N.C., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Tenax TherapeuAloner-11/13/2023 The latest on a glp-1 drug: To me the biggest concern isoftware salesperson211/12/2023
52098eric topol's latest substack on nasal vaccines at: esoftware salesperson410/15/2023
52097Geez just a couple day bounce after my last post and now on to new lows. The CriJamesK-10/2/2023 scroll up how to interpret free home rapid covid salesperson-9/27/2023 Eric Topol analyzes: When the Breakthrough Obesity G-Agsoftware salesperson29/27/2023
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):